SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing heightened market activity following a private debt exchange that retired a significant portion of its convertible notes for equity, sparking intense debate among investors regarding potential dilution versus long-term balance sheet strengthening. Community members are actively discussing whether this financial maneuver acts as a strategic precursor to a potential acquisition, leading to speculative discussions over its impact on future price volatility.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as investors focus on recent store expansion and the company's ability to maintain growth despite broader economic headwinds. Community sentiment is largely driven by optimism surrounding upcoming earnings and the potential for increased margin efficiency, though debates persist regarding the stock's OTC status and the impact of the ongoing share repurchase program.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investor optimism builds following the launch of a new clinical trial exploring Briumvi for schizophrenia and a series of analyst price target revisions that highlight its rapid commercial growth. The community is actively discussing the stock's potential as a buyout candidate, emphasizing its strong revenue trajectory and the strategic advantages of its expanded pipeline.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing significant market volatility as it approaches its first earnings report and the initial expiration of insider lock-up periods, which will flood the market with nearly a billion newly tradable shares. The community remains deeply divided, with bears pointing to massive dilution and valuation concerns while bulls argue that long-term infrastructure potential and institutional backing make recent price dips a buying opportunity.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing heightened market attention driven by reports of potential mega-merger talks with AstraZeneca, a move that could reshape global oncology and create one of the industry's largest companies. Investors are actively debating the strategic logic behind the proposed combination, specifically focusing on the potential for massive cost-cutting, structural synergies in cancer portfolios, and whether the deal can successfully navigate complex antitrust and regulatory scrutiny.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is trending due to significant community debate regarding its stock valuation and recent theatrical success, with investors actively discussing potential box office tailwinds from new IP like 'Spider-Man: Brand New Day' alongside long-term strategic concerns. The discourse is heavily divided between bulls highlighting an unmatched intellectual property portfolio and value-based entry points, and bears expressing frustration over prolonged share price stagnation and ongoing leadership debates.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is drawing significant market attention following reports of preliminary merger discussions with Bristol Myers Squibb aimed at creating a $400 billion pharmaceutical powerhouse. Community discourse is heavily focused on the potential for massive operational cost-cutting, oncology portfolio synergies, and the regulatory hurdles such a large-scale consolidation might face.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as market participants debate the intensity of the memory supercycle, with bulls pointing to strong AI demand and supply constraints while bears focus on potential competition and macro-driven sell-offs. The community remains heavily divided, with intense discussions around institutional manipulation, the impact of geopolitical tensions, and whether the stock's low valuation reflects a buying opportunity or structural risk.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella is seeing significant investor attention following reports that NXP Semiconductors is exploring a potential multi-billion dollar acquisition of the edge AI chip designer. The community remains focused on the strategic value of Ambarellas computer vision technology for automotive and robotics applications, while monitoring the ongoing volatility as traders react to both the potential takeover premium and mixed financial performance.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is experiencing high volatility as investors weigh strong earnings performance and a robust contracted backlog against cautious full-year revenue guidance. The community remains deeply divided, with some traders targeting the stock for tactical scalp plays while others debate the long-term impact of regulatory tariffs and ongoing securities class action concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RiverNorth Closed-End Funds Declare Monthly Distributions

In accordance with the RiverNorth closed-end funds (the Funds) level distribution policies, the Funds have established the distribution dates for April, May, and June 2026. The payments of the...

In accordance with the RiverNorth closed-end funds (the Funds) level distribution policies, the reset distribution rates have been proposed for the calendar year 2026, as detailed below. Further, the...

RiverNorth Opportunistic Municipal Income Fund, Inc. operates as Closed-End Investment Fund/Investment Trust. It specializes in opportunistic investment strategies in niche markets. The firm operates as investment manager to registered funds, private funds and separately managed accounts. The company is headquartered in West Palm Beach, FL.

RiverNorth Opportunistic Municipal Income Fund Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$15.65
Prev Close	$15.15
Open	$15.30
Dividend Yield	8.04%
50-Day Moving Average	$15.38
Beta	0.24
Avg. Volume	11,706.31
PE Ratio	128.59

52-Week High	$16.36
52-Week Low	$13.71
Market Capitalization	$99.76M
EPS (Annual)	-$0.6262
Price to Book	0.99
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info